LA
CELG

Legacy Advisors’s Celgene Corp CELG Stock Holding History

Legacy Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$18K – 366
2019
Q2 		$18K Buy
200
+48
+32% +$4.56K 0.01% 266
2019
Q1 		$14K Buy
+152
New +$13.3K ﹤0.01% 307
2018
Q4 		– Sell
-236
Closed -$21K – 462
2018
Q3 		$21K Buy
236
+84
+55% +$7.42K 0.01% 295
2018
Q2 		$12K Hold
152
– – 0.01% 297
2018
Q1 		$14K Hold
152
– – 0.01% 239
2017
Q4 		$15K Sell
152
-50
-25% -$5.64K 0.01% 212
2017
Q3 		$29K Buy
+202
New +$27.5K 0.03% 141

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Legacy Advisors's CELG Position: Q3 2019 in Review

Legacy Advisors sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 200 shares — an estimated $18K sold.

Legacy Advisors first reported a position in CELG in Q3 2017 and held it in 7 quarters. The position peaked at $29K in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Legacy Advisors reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Legacy Advisors sold 200 Celgene Corp shares in Q3 2019, an estimated $18K.
  • Legacy Advisors first reported a position in Celgene Corp in Q3 2017 and held it in 7 quarters.
  • Legacy Advisors's Celgene Corp position peaked at $29K in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Legacy Advisors's 13F filing for Q3 2019, filed 10 Oct 2019.